India to United States: Cisplatin Export Trade Route
India has recorded 19 verified shipments of Cisplatin exported to United States, representing a combined trade value of $887.2K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $46.7K USD. The leading Indian exporter is GLAND PHARMA LIMITED, which accounts for 60% of total export value with 11 shipments worth $530.1K USD. On the buying side, SCIEGEN PHARMACEUTICALS INC is the largest importer in United States with $329.4K USD in purchases. The top 3 suppliers — GLAND PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Cisplatin corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $887.2K USD. The route is dominated by GLAND PHARMA LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's cisplatin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $46.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with cisplatin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 34.3%, placing it at rank #12 among India's top cisplatin export destinations globally.
On the import side, key buyers of Indian cisplatin in United States include SCIEGEN PHARMACEUTICALS INC, XXCORXXHEAXXHCAXX INXX, Fosun Pharma USA Inc and 4 others. SCIEGEN PHARMACEUTICALS INC is the single largest importer with 7 shipments valued at $329.4K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ4
- Primary modeSea freight
- Top portVizagepzsez
Market Position
- Global rank#12
- Annual growth+34.3%
- Demand growth+29.7%
- Regulatory ease87/100
Top 10 Indian Cisplatin Exporters to United States
Showing top 10 of 4 Indian suppliers exporting Cisplatin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LIMITED Avg $48.2K per shipment | 11 | $530.1K | 59.7% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $92.6K per shipment | 3 | $277.9K | 31.3% |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED Avg $19.8K per shipment | 4 | $79.2K | 8.9% |
| 4 | SPECIALITY MEDICINES PRIVATE LIMITED Avg $68 per shipment | 1 | $68 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting cisplatin to United States, ranked by total trade value. The listed exporters are: GLAND PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, SPECIALITY MEDICINES PRIVATE LIMITED. GLAND PHARMA LIMITED is the dominant supplier with 11 shipments worth $530.1K USD, giving it a 60% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Cisplatin Importers in United States
Showing top 10 of 7 known buyers in United States receiving Cisplatin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cisplatin in United States include SCIEGEN PHARMACEUTICALS INC, XXCORXXHEAXXHCAXX INXX, Fosun Pharma USA Inc, FRESENIUS KABI USA LLC, ACCORD HEALTHCARE INC, among 7 total buyers. The largest importer is SCIEGEN PHARMACEUTICALS INC, accounting for $329.4K USD across 7 shipments — representing 37% of all cisplatin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SCIEGEN PHARMACEUTICALS INC | 7 | $329.4K | 37.1% |
| 2 | XXCORXXHEAXXHCAXX INXX | 2 | $208.0K | 23.4% |
| 3 | Fosun Pharma USA Inc | 4 | $200.6K | 22.6% |
| 4 | FRESENIUS KABI USA LLC | 3 | $79.0K | 8.9% |
| 5 | ACCORD HEALTHCARE INC | 1 | $69.9K | 7.9% |
| 6 | IRVINE MEDICAL PRODUCTS LABORATORY | 1 | $203 | 0.0% |
| 7 | USA | 1 | $68 | 0.0% |
Top 10 Cisplatin Formulations Imported by United States
Showing top 10 of 10 product formulations shipped on the India to United States Cisplatin route, ranked by trade value
United States imports a wide range of cisplatin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CISPLATIN INJ 1 MG/ML 100 ML — accounts for $277.9K USD across 3 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CISPLATIN INJ 1 MG/ML 100 ML | 3 | $277.9K | 31.3% |
| 2 | CISPLATIN INJECTION 100MG X 1 100ML | 4 | $182.2K | 20.5% |
| 3 | CISPLATIN INJECTION 100MG/100ML | 3 | $149.8K | 16.9% |
| 4 | CISPLATIN 50MG PER 50ML | 2 | $101.3K | 11.4% |
| 5 | KEMOPLAT CISPLATIN BP INJ. 50MG/50ML VIAL BATCH NO. 87230281AB MANUFACTURING . DT. 06/2023 EXP. DT. 05/2025 | 2 | $78.9K | 8.9% |
| 6 | CISPLATIN INJECTION 50MG/50ML | 1 | $50.8K | 5.7% |
| 7 | CISPLATIN INJECTION | 1 | $45.9K | 5.2% |
| 8 | KEMOPLAT CISPLATIN INJ.BP 50MG/50ML BA | 1 | $203 | 0.0% |
| 9 | HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE CISPLATIN 50MG INJECTIONSET | 1 | $68 | 0.0% |
| 10 | KEMOPLATCISPLATININJ.50MG/50ML BNO.872 | 1 | $48 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Vizagepzsez handles the highest volume with 7 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's cisplatin exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 100% of total trade value on this route. The average shipment value of $46.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cisplatin injection 100mg x 1 100ml and cisplatin injection 100mg/100ml, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SCIEGEN PHARMACEUTICALS INC is the largest importer with 7 shipments worth $329.4K USD — representing 37% of all cisplatin imports from India on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $887.2K
- Avg. Shipment
- $46.7K
- Suppliers
- 4
- Buyers
- 7
- Transit (Sea)
- ~29 days
- Annual Growth
- +34.3%
Reverse Direction
United States → India — Cisplatin (Import)Other Cisplatin Routes
Unlock the Full India to United States Cisplatin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 19 shipments on this route.
Frequently Asked Questions — India to United States Cisplatin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cisplatin to United States?
The leading Indian exporters of Cisplatin to United States are GLAND PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED. GLAND PHARMA LIMITED holds the largest market share at approximately 60% of total trade value on this route.
Q What is the total value of Cisplatin exports from India to United States?
India exports Cisplatin to United States worth approximately $887.2K USD across 19 recorded shipments. The average value per shipment is $46.7K USD.
Q Which ports does India use to ship Cisplatin to United States?
The most active port of origin is Vizagepzsez with 7 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Cisplatin?
The average transit time for Cisplatin shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Cisplatin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 34.3% with demand growth tracking at 29.7%. The route is ranked #12 among India's top Cisplatin export destinations globally.
Q How many suppliers are active on the India to United States Cisplatin route?
There are currently 4 active Indian suppliers exporting Cisplatin to United States. The market is moderately concentrated with GLAND PHARMA LIMITED accounting for 60% of total shipment value.
Q Who are the main importers of Cisplatin from India in United States?
The leading importers of Indian Cisplatin in United States include SCIEGEN PHARMACEUTICALS INC, XXCORXXHEAXXHCAXX INXX, Fosun Pharma USA Inc, FRESENIUS KABI USA LLC, ACCORD HEALTHCARE INC. SCIEGEN PHARMACEUTICALS INC is the largest buyer with 7 shipments worth $329.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Cisplatin.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 7 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 19 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists